Who is now responsible for discovering and warning about adverse effects of generic drugs?

JAMA. 2013 Sep 11;310(10):1023-4. doi: 10.1001/jama.2013.228349.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Databases, Factual
  • Drug Industry
  • Drug Labeling*
  • Drugs, Generic / adverse effects*
  • Female
  • Humans
  • Legislation, Drug
  • Pharmacoepidemiology / trends*
  • Product Surveillance, Postmarketing / methods*
  • Product Surveillance, Postmarketing / statistics & numerical data
  • Risk
  • Sentinel Surveillance
  • Supreme Court Decisions*
  • United States
  • United States Food and Drug Administration

Substances

  • Drugs, Generic